Printing the Future of Therapeutics in 3D
May 6-8, 2020
Peter Wall Institute for Advanced Studies
Vancouver, BC, Canada
FOSTERING RELATIONSHIPS AND DEVELOPING COLLABORATIONS
PFT3D is an exclusive roundtable event centred around facilitating discussion and collaboration on the development of commercially and clinically relevant life-saving tissues.
Aspect Biosystems and The University of British Columbia are proud to be co-organizing the fourth annual international symposium on Printing the Future of Therapeutics in 3D (PFT3D).
Last year’s inaugural event saw speakers from a wide variety of both academia and industry to discuss the amazing potential and applications of 3D bioprinting. This year, the event will take place over 3 days and includes 20 speakers, covering four key areas:
Functional biofabricated tissues for disease modeling, therapeutic discovery, and regenerative medicine
Platform technologies to recreate biological function
Biomaterials for the development of functional tissues
An industry perspective on tissue engineering technologies
By the end of this meeting, we want you to leave with new inspirational ideas on groundbreaking projects, new partners and opportunities for collaboration, and a fresh perspective on the needs of industry and the translation of academic research.
In addition to our roundtable talks, there will be focused discussion sessions to address a variety of key challenges in our industry and facilitated networking sessions to stimulate interactions.
2019 SPEAKERS & PANELLISTS
Speakers & Panellists
- Elizabeth Aisenbrey
Postdoctoral Trainee in Vascular Surgery and Biomedical Engineering, University of Wisconsin
- David Ballard
Radiology Resident, Mallinckrodt Institute of Radiology, Washington University School of Medicine
- Andreas R. Baudy
Assoc. Principal Scientist, Safety Assessment Department, Merck & Co., Inc
- Robert A. Blake
Scientist in Biochemical and Cellular Pharmacology, Genentech, Inc.
- Akhilesh K. Gaharwar
Assistant Professor of Biomedical Engineering, Texas A&M University
- Sepideh H. Hagvall
Associate Principal Scientist, AstraZeneca and Adjunct Professor in Molecular Biology, Skövde University, Sweden
- Jeremy Hirota
Canada Research Chair in Respiratory Mucosal Immunology, Assistant Professor of Medicine – McMaster University, Assistant Professor of Medicine (Affiliate) – UBC
- Jinah Jang
Assistant Professor, Pohang University of Science and Technology (POSTECH)
- Anna Jezierski
Research Scientist, Human Health Therapeutics, National Research Council Canada
- Jean-Louis Klein
Director, Target & Pathway Validation, GlaxoSmithKline
- Tamer Mohamed
President & CEO, Aspect Biosystems
- John F. Trant
Assistant Professor, Department of Chemistry and Biochemistry and the Canadian Centre for Alternatives to Animal Methods, University of Windsor
- Stephanie Willerth
Associate Professor and Canada Research Chair in Biomedical Engineering, University of Victoria
- Bill Yackabonis
Technical Manager, Autodesk
- Peter Zandstra
Director, School of Biomedical Engineering and Professor, Department of Medical Genetics, UBC
- Boyang Zhang
Assistant Professor, Department of Chemical Engineering, McMaster University
- Yu Shrike Zhang
Associate Bioengineer and Faculty, Division of Engineering in Medicine, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School
Over the two days, we will have influential innovators from around the world discussing the latest technological advances and challenges of bioprinting living human tissues.
CLICK ON EACH DAY BELOW FOR DETAILED AGENDA
Full program can be downloaded HERE.
8:15-9:00am: Breakfast & Registration
9:00-4:00pm: Talks & Interactive Discussion
5:00pm: informal eats and drinks on campus OR
shuttle departs for Speakers’ Reception (invite only)
9:00-3:30pm: Talks & Interactive Discussion
3:30pm: Close of PFT3D 2019
VENUE & HOSTS
We are proud to be hosting this International Research Roundtable at the Peter Wall Institute for Advanced Studies on the beautiful University of British Columbia (UBC) campus in Vancouver, BC.
The Peter Wall Institute for Advanced Studies at the University of British Columbia (UBC) provides funding opportunities and an intellectual environment scholars are free to pursue the collaborative exchange of ideas beyond disciplinary boundaries.
The Institute’s goal is to stimulate creative, innovative research that makes important advances in knowledge, and to share or implement these ideas through ongoing community engagement. The Institute achieves this by supporting a highly collaborative environment at UBC where scholars have the opportunity to exchange ideas with national and international scholars, develop new thinking and engage in intellectual risk-taking.
The University of British Columbia is a global centre for research and teaching, consistently ranked among the 40 best universities in the world. Since 1915, UBC’s West Coast spirit has embraced innovation and challenged the status quo. Its entrepreneurial perspective encourages students, staff and faculty to challenge convention, lead discovery and explore new ways of learning. At UBC, bold thinking is given a place to develop into ideas that can change the world.
Aspect Biosystems is a privately held biotechnology company pioneering microfluidic 3D bioprinting of living, human tissue. The company’s proprietary technology is enabling advances in understanding fundamental biology, disease research, development of novel therapeutics, and regenerative medicine. In addition to its internal programs, Aspect is focused on strategically partnering with pharmaceutical and biotechnology companies, as well as academic researchers, to enable the creation of living, human tissues for medical research, therapeutic discovery, and regenerative medicine products.